title: Most children with eosinophilic esophagitis have a favorable outcome as young adults.
abstract: The disease progression of eosinophilic esophagitis (EoE) from childhood into adulthood is unclear. To determine the clinical outcome of patients who were diagnosed with EoE as children, and who now are young adults. Children (<18 years old) diagnosed with EoE were enrolled in a prospective registry on demographics, presenting symptoms, and endoscopic/histologic findings. Subjects who now are adults (≥18 years old) were identified, and a structured telephone interview was conducted to obtain follow-up data on symptom prevalence (dysphagia to solids and liquids, nausea/vomiting, abdominal pain, and heartburn/regurgitation), food impaction, medication usage, health-care utilization, and resolution of atopy/food allergies. A favorable outcome was defined if EoE symptoms were resolved or improved by subjects' assessment. Unfavorable outcomes was defined as symptoms same or worse. Clinical variables that predicted a favorable outcome as an adult were examined. Mayo Dysphagia Scale (MDQ-30: scored 0-100) was administered to validate the outcome assessment. Mantel-Haenszel odds ratio and unpaired t-test were used. Fifty-eight subjects (64% male) who met study criteria were enrolled. Mean age at diagnosis was 12 years (range 4-17) and mean duration of follow-up was 8.3 years (2-16). As children, the most common presenting symptoms were abdominal pain (54%), dysphagia (33%), and vomiting (24%). As young adults, 47 subjects (81%) had a favorable outcome. Total MDQ-30 scores were 4.6 (0-30) and 14.1 (0-50) in subjects with favorable outcome and unfavorable outcome, respectively (P = 0.015). Two-thirds of subjects did not use steroids or proton pump inhibitors in the preceeding 12 months. Male children with EoE were four times more likely to have a favorable outcome as young adults compared with female children. Females were more likely to report nausea/vomiting as young adults (odds ratio 3.23, CI 0.97-10.60). Of all presenting symptoms in EoE children, dysphagia was the most likely to persist into adulthood (odds ratio 6.29, CI 1.85-21.38). Eighty one percent of EoE children had a favorable outcome as young adults. Most patients with symptom resolution did not require any form of steroid therapy or seek healthcare.
authors.affiliation: Division of Gastroenterology and Hepatology, Indiana University School of Medicine and Indiana University Health, Indianapolis, Indiana, USA.
authors.forename: M
authors.initials: M
authors.lastname: Bohm
authors.affiliation: Division of Gastroenterology and Hepatology, Indiana University School of Medicine and Indiana University Health, Indianapolis, Indiana, USA.
authors.forename: J W
authors.initials: JW
authors.lastname: Jacobs
authors.affiliation: Division of Gastroenterology and Hepatology, Indiana University School of Medicine and Indiana University Health, Indianapolis, Indiana, USA.
authors.forename: A
authors.initials: A
authors.lastname: Gupta
authors.affiliation: Division of Gastroenterology and Hepatology, Indiana University School of Medicine and Indiana University Health, Indianapolis, Indiana, USA.
authors.forename: S
authors.initials: S
authors.lastname: Gupta
authors.affiliation: Division of Gastroenterology and Hepatology, Indiana University School of Medicine and Indiana University Health, Indianapolis, Indiana, USA.
authors.forename: J M
authors.initials: JM
authors.lastname: Wo
mesh_terms: D015746:Abdominal Pain / Q000209:etiology / Q000503:physiopathology*; D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000553:Ambulatory Care / Q000706:statistics & numerical data; D003680:Deglutition Disorders / Q000209:etiology / Q000503:physiopathology*; D018450:Disease Progression; D004636:Emergency Service, Hospital / Q000706:statistics & numerical data; D057765:Eosinophilic Esophagitis / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology*; D005260:Female; D005500:Follow-Up Studies; D005512:Food Hypersensitivity; D006296:Health Services / Q000706:statistics & numerical data; D006356:Heartburn / Q000209:etiology / Q000503:physiopathology*; D006801:Humans; D008297:Male; D009325:Nausea / Q000209:etiology / Q000503:physiopathology*; D016017:Odds Ratio; D054328:Proton Pump Inhibitors / Q000627:therapeutic use; D012042:Registries; D014839:Vomiting / Q000209:etiology / Q000503:physiopathology*; D055815:Young Adult
chemical_list: D000305:Adrenal Cortex Hormones; D054328:Proton Pump Inhibitors
keywords: acid reflux; dysphagia; eosinophilic esophagitis; eosinophilic oesophagitis; eosinophils